Genetic polymorphism involved in major depressive disorder: a systemic review and meta-analysis

被引:1
|
作者
Suktas, Areeya [1 ]
Ekalaksananan, Tipaya [1 ]
Aromseree, Sirinart [1 ]
Bumrungthai, Sureewan [2 ]
Songserm, Nopparat [3 ]
Pientong, Chamsai [1 ]
机构
[1] Khon Kaen Univ, Fac Med, Dept Microbiol, Khon Kaen, Thailand
[2] Ubon Ratchathani Univ, Fac Pharmaceut Sci, Ubon Ratchathani, Thailand
[3] Ubon Ratchathani Rajabhat Univ, Fac Publ Hlth, Ubon Ratchathani, Thailand
关键词
Single nucleotide polymorphism; BDNF; Major depressive disorder; SEROTONIN TRANSPORTER GENE; SUBSTANCE USE; MESSENGER-RNA; ASSOCIATION; SLC6A4; RISK; BDNF; EXPRESSION; VARIANTS; TRAFFICKING;
D O I
10.1186/s12888-024-06195-z
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background and objectiveGenetic polymorphism studies in families and twins indicated the heritability of depression. However, the association between genes with genetic polymorphism and depression provides various findings and remains unclear. Therefore, we conducted a systematic review and meta-analysis to determine the genes with their polymorphism associated with the symptomatic depression known as major depressive disorder (MDD).Materials and methodsPubMed and Scopus were searched for relevant studies published before May 22, 2023 (1968-2023), and 62 were selected for this review. The study's bias risk was investigated using the Newcastle-Ottawa scale. Gene functional enrichment analysis was investigated for molecular function (MF) and biological process (BP) and pathways. A meta-analysis of the studied genes that were replicative in the same single nucleotide polymorphism was conducted using a random-effect model.ResultsThe 49 genes involved in MDD were studied and engaged in several pathways, such as tryptophan metabolism or dopaminergic and serotonergic synapses. Based on gene overlapping in MF and BP, 13 genes with polymorphisms were identified as related to MDD. Most of them were only studied once. Solute carrier family 6 member 4 (SLC6A4) overlapping between MF and BP and brain-derived neurotrophic factor (BDNF) as unique to BP were replicative studied and used in the meta-analysis. The polymorphism of SLC6A4 SS and LS genotypes increased the occurrence of MDD development but not significantly [odd ratio (OR) = 1.39; 95% confidence interval (CI) = 0.87-2.22; P = 0.16 and OR = 1.13; 95% CI = 0.84-1.53; P = 0.42, respectively]. A similar result was observed for BDNF rs6265 GG (OR = 1.26; 95% CI = 0.78-2.06; P = 0.35) and BDNF rs6265 AA genotypes (OR = 1.12; 95% CI = 0.77-1.64; P = 0.56). These studies indicated low bias and significant heterogeneity.ConclusionAt least 13 studied genes with polymorphisms were involved in MDD development according to MF and BP, but not significantly. These results suggest that MDD development risk factors might require genetic and other factors for interaction and induction.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Prevalence of major depressive disorder in children and adolescents in China: A systematic review and meta-analysis
    Xu Dan-Dan
    Rao Wen-Wang
    Cao Xiao-Lan
    Wen Si-Ying
    Che Weng-Ian
    Chee, Ng H.
    Ungvari, Gabor S.
    Du Yasong
    Zhang Ling
    Xiang Yu-Tao
    JOURNAL OF AFFECTIVE DISORDERS, 2018, 241 : 592 - 598
  • [42] Marriage and postpartum major depressive disorder: A systematic review and meta-analysis of cohort studies
    Wei, Meng
    Qin, Yan
    Niu, Xingmeng
    Niu, Sifang
    Mu, Fuqin
    Yang, Lu
    Li, Ying
    Zhang, Ying
    Wang, Jianli
    Liu, Yan
    JOURNAL OF PSYCHIATRIC RESEARCH, 2025, 182 : 83 - 91
  • [43] Neuroendocrine Biomarkers of Herbal Medicine for Major Depressive Disorder: A Systematic Review and Meta-Analysis
    Seung, Hye-Bin
    Kwon, Hui-Ju
    Kwon, Chan-Young
    Kim, Sang-Ho
    PHARMACEUTICALS, 2023, 16 (08)
  • [44] The efficacy of vortioxetine in the acute treatment of major depressive disorder: A systematic review and meta-analysis
    Berardelli, Isabella
    Rogante, Elena
    Formica, Federico
    Iannazzo, Riccardo
    Mammoliti, Attilio Valerio
    Riccioni, Raffaele
    Veizi, Skender
    Mcintyre, Roger S.
    Pompili, Maurizio
    JOURNAL OF PSYCHOPHARMACOLOGY, 2025, 39 (02) : 92 - 105
  • [45] Sequential Combination of Pharmacotherapy and Psychotherapy in Major Depressive Disorder A Systematic Review and Meta-analysis
    Guidi, Jenny
    Fava, Giovanni A.
    JAMA PSYCHIATRY, 2021, 78 (03) : 261 - 269
  • [46] Statins for major depressive disorder: A systematic review and meta-analysis of randomized controlled trials
    De Giorgi, Riccardo
    De Crescenzo, Franco
    Rizzo Pesci, Nicola
    Martens, Marieke
    Howard, Wendy
    Cowen, Philip J.
    Harmer, Catherine J.
    PLOS ONE, 2021, 16 (03):
  • [47] P300 parameters in major depressive disorder: A systematic review and meta-analysis
    Arikan, Mehmet Kemal
    Ilhan, Reyhan
    Orhan, Ozden
    Esmeray, Muhammed Taha
    Turan, Senol
    Gica, Sakir
    Bakay, Hasan
    Pogarell, Oliver
    Tarhan, Kasif Nevzat
    Metin, Baris
    WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2024, 25 (04): : 255 - 266
  • [48] Prevalence of Suicidality in Major Depressive Disorder: A Systematic Review and Meta-Analysis of Comparative Studies
    Cai, Hong
    Xie, Xiao-Meng
    Zhang, Qinge
    Cui, Xiling
    Lin, Jing-Xia
    Sim, Kang
    Ungvari, Gabor S.
    Zhang, Ling
    Xiang, Yu-Tao
    FRONTIERS IN PSYCHIATRY, 2021, 12
  • [49] Prevalence of major depressive disorder in older adults in China: A systematic review and meta-analysis
    Fei, Wang
    Zhang Qing-E
    Ling, Zhang
    Chee, Ng H.
    Ungvari, Gabor S.
    Zhen, Yuan
    June, Zhang
    Ling, Zhang
    Xiang Yu-Tao
    JOURNAL OF AFFECTIVE DISORDERS, 2018, 241 : 297 - 304
  • [50] Newer antidepressant for Japanese adults with major depressive disorder: A systematic review and meta-analysis
    Kishi, Taro
    Sakuma, Kenji
    Hatano, Masakazu
    Matsuda, Yuki
    Esumi, Satoru
    Miyake, Nobumi
    Miura, Itaru
    Hori, Hikaru
    Kato, Masaki
    Iwata, Nakao
    NEUROPSYCHOPHARMACOLOGY REPORTS, 2024, 44 (01) : 216 - 220